Advertisement
Screener

Sensus Healthcare, Inc. (SRTS) ROA

Sensus Healthcare, Inc. ROA

Return on assets (ROA) is the profit a company earns for every dollar of assets it uses, shown as a percentage. It is net income divided by total assets, and the table shows both amounts. Because assets are funded by lenders as well as shareholders, ROA is not inflated by borrowing the way ROE can be, and it is naturally lower for businesses that need many factories, stores or other assets. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • Sensus Healthcare, Inc. roa for the quarter ending 2026-06-30 was -37.53%, a change of -36.09% year-over-year.
  • Sensus Healthcare, Inc. roa for the quarter ending 2026-03-31 was -15.08%, a 604.14% decline year-over-year.
  • Sensus Healthcare, Inc. roa for the quarter ending 2025-12-31 was -14.55%, a 236.11% decline year-over-year.
  • Sensus Healthcare, Inc. roa for the quarter ending 2025-09-30 was -5.16%, a 133.15% decline year-over-year.
  • Sensus Healthcare, Inc. roa for fiscal 2025 was -14.55%, a 236.11% decline from fiscal 2024.
  • Sensus Healthcare, Inc. roa for fiscal 2024 was 10.69%, a 1084.11% increase from fiscal 2023.
  • Sensus Healthcare, Inc. roa for fiscal 2023 was 0.90%, a 97.89% decline from fiscal 2022.
  • Sensus Healthcare, Inc. roa for fiscal 2022 was 42.73%, a 234.47% increase from fiscal 2021.
Available history
2015-12-31 to 2026-06-30
Data captured

Historical ROA

DateROANet income 12 monthNet income 3 monthTotal assets
2026-06-30-37.53%-$15.49M-$8.75M$41.26M
2026-03-31-15.08%-$7.77M-$2.63M$51.55M
2025-12-31-14.55%-$7.72M-$3.17M$53.04M
2025-09-30-5.16%-$3.01M-$943.00K$58.3M
2025-06-30-1.44%-$848,000.00-$1.04M$58.85M
2025-03-312.99%$1.8M-$2.57M$60.21M
2024-12-3110.69%$6.65M$1.55M$62.17M
2024-09-3015.56%$9.31M$1.22M$59.86M
2024-06-3011.42%$6.65M$1.61M$58.16M
2024-03-318.12%$4.65M$2.27M$57.27M
2023-12-310.90%$485,000.00$4.21M$53.71M
2023-09-30-1.77%-$896,000.00-$1.45M$50.55M
2023-06-304.58%$2.38M-$380.00K$52.02M
2023-03-3111.78%$6.29M-$1.89M$53.4M
2022-12-3142.73%$24.24M$2.83M$56.74M
2022-09-3048.82%$26.73M$1.83M$54.76M
2022-06-3044.54%$25.1M$3.52M$56.35M
2022-03-3139.49%$21.3M$16.06M$53.93M
2021-12-3112.78%$4.12M$5.32M$32.24M
2021-09-30-0.71%-$181,000.00$195.00K$25.63M
2021-06-30-7.84%-$2.07M-$279.00K$26.36M
2021-03-31-16.48%-$4.36M-$1.11M$26.48M
2020-12-31-24.40%-$6.84M$1.02M$28.01M
2020-09-30-24.58%-$6.81M-$1.69M$27.72M
2020-06-30-19.70%-$5.85M-$2.57M$29.71M
2020-03-31-9.79%-$3.17M-$3.59M$32.35M
2019-12-31-4.60%-$1.7M$1.04M$36.92M
2019-09-30-7.36%-$2.64M-$730.39K$35.82M
2019-06-30-6.60%-$2.36M$112.31K$35.85M
2019-03-31-8.95%-$3.02M-$2.12M$33.72M
2018-12-31-6.08%-$2.02M$101.91K$33.25M
2018-09-30-7.78%-$2.53M-$458.11K$32.54M
2018-06-30-15.11%-$3.04M-$540.65K$20.12M
2018-03-31-15.98%-$3.26M-$1.13M$20.43M
2017-12-31-19.70%-$3.71M-$408.58K$18.84M
2017-09-30-18.04%-$3.27M-$965.69K$18.12M
2017-06-30-12.39%-$2.33M-$764.11K$18.83M
2017-03-31-10.06%-$1.92M-$1.57M$19.1M
2016-12-31-1.83%-$346,448.00$33.18K$18.95M
2016-09-300.19%$35,183.00-$30.41K$18.16M
2016-06-30-0.06%-$12,476.00-$351.30K$20.58M

Annual ROA

DateROANet income 12 monthTotal assets
2025-12-31-14.55%-$7.72M$53.04M
2024-12-3110.69%$6.65M$62.17M
2023-12-310.90%$485,000.00$53.71M
2022-12-3142.73%$24.24M$56.74M
2021-12-3112.78%$4.12M$32.24M
2020-12-31-24.41%-$6.84M$28.01M
2019-12-31-4.60%-$1.7M$36.92M
2018-12-31-6.08%-$2.02M$33.25M
2017-12-31-19.70%-$3.71M$18.84M
2016-12-31-1.83%-$346,448.00$18.95M
2015-12-31-2.46%-$237,267.00$9.64M

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEPHROS INC (NEPH)United States$0.046B23.02
Spectral AI, Inc. (MDAI)United States$0.052B
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
SANUWAVE Health, Inc. (SNWV)United States$0.041B5.47
TELA Bio, Inc. (TELA)United States$0.057B-0.82
InspireMD, Inc. (NSPR)$0.033B
PAVmed Inc. (PAVM)United States$0.031B-3.00
DarioHealth Corp. (DRIO)$0.066B-1.39
CVRx, Inc. (CVRX)United States$0.067B-2.62
Glucotrack, Inc. (GCTK)United States$0.027B